A药品名称: B药品名称: B与A对换
 药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
A药品
B药品
详细
Allylestrenol
Sulodexide
The therapeutic efficacy of Calcium citrate can be decreased when used in combination with Sulodexide.
Allylestrenol
Prasugrel
The therapeutic efficacy of Calcium citrate can be decreased when used in combination with Prasugrel.
Allylestrenol
Fibrinolysin
The therapeutic efficacy of Calcium citrate can be decreased when used in combination with Fibrinolysin.
Allylestrenol
Beraprost
The therapeutic efficacy of Calcium citrate can be decreased when used in combination with Beraprost.
Allylestrenol
Ancrod
The therapeutic efficacy of Calcium citrate can be decreased when used in combination with Ancrod.
Allylestrenol
Defibrotide
The therapeutic efficacy of Calcium citrate can be decreased when used in combination with Defibrotide.
Allylestrenol
Desmoteplase
The therapeutic efficacy of Calcium citrate can be decreased when used in combination with Desmoteplase.
Allylestrenol
Ximelagatran
The therapeutic efficacy of Calcium citrate can be decreased when used in combination with Ximelagatran.
Allylestrenol
Coumarin
The therapeutic efficacy of Calcium citrate can be decreased when used in combination with Coumarin.
Allylestrenol
4-hydroxycoumarin
The therapeutic efficacy of Calcium citrate can be decreased when used in combination with 4-hydroxycoumarin.
Allylestrenol
Monteplase
The therapeutic efficacy of Calcium citrate can be decreased when used in combination with Monteplase.
Allylestrenol
Camostat
Camostat may increase the thrombogenic activities of Calcium citrate.
Allylestrenol
Aminomethylbenzoic acid
Aminomethylbenzoic acid may increase the thrombogenic activities of Calcium citrate.
Allylestrenol
Hydrogen peroxide
Hydrogen peroxide may increase the thrombogenic activities of Calcium citrate.
Allylestrenol
Aprotinin
Aprotinin may increase the thrombogenic activities of Calcium citrate.
Allylestrenol
Phosphate ion
Calcium citrate can cause a decrease in the absorption of Phosphate ion resulting in a reduced serum concentration and potentially a decrease in efficacy.
Allylestrenol
Sodium tripolyphosphate
Calcium citrate can cause a decrease in the absorption of Sodium tripolyphosphate resulting in a reduced serum concentration and potentially a decrease in efficacy.
Allylestrenol
Dipotassium phosphate
Calcium citrate can cause a decrease in the absorption of Dipotassium phosphate resulting in a reduced serum concentration and potentially a decrease in efficacy.
Allylestrenol
Monopotassium phosphate
Calcium citrate can cause a decrease in the absorption of Monopotassium phosphate resulting in a reduced serum concentration and potentially a decrease in efficacy.
Allylestrenol
Ferric pyrophosphate
Calcium citrate can cause a decrease in the absorption of Ferric pyrophosphate resulting in a reduced serum concentration and potentially a decrease in efficacy.
免责声明:以上所展示的信息由企业自行提供,内容的真实性、准确性和合法性由发布企业负责,医药网对此不承担任何责任。
相关链接:医药研究数据| 医药资料| SDA药品评审中心| 中医网| 中药处方系统| 爱视立眼贴
专业提供药品信息、药品招商、药品代理、保健品招商、医药原料采购供应的中国药品信息网站平台
版权所有 © 2003-2028 盗冒必究  客服热线:0575-83552251 / 13754370441  QQ客服:药品信息客服
浙ICP备16010490号-2 增值电信业务经营许可证:浙B2-20220931 互联网药品信息服务资格证书编号:(浙)-经营性2023-0215 浙公网安备:330683240604819103159
 医药代理商群1:药药网药品采购交流医药代理商群2:药药网药品采购交流2医药代理商群3:药药网药品采购交流3